InflaRx (IFRX) director details vested and future stock options
Rhea-AI Filing Summary
InflaRx N.V. director Hege Hellstrom has filed an initial ownership report showing existing stock option holdings in the company. The filing lists four stock option awards over ordinary shares with exercise prices of $4.19, $1.79, $2.41 and $1.17 per share and expirations from May 2033 through January 2036.
Options granted on May 31, 2023, January 5, 2024 and January 3, 2025 covering 22,500, 30,000 and 30,000 underlying ordinary shares are fully vested and exercisable. A further option granted on January 6, 2026 for 30,000 shares will vest in four equal quarterly installments of 7,500 shares, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
4 transactions reported
Mixed
4 txns
Insider
Hellstrom Hege
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 22,500 shares (Direct)
Footnotes (1)
- This option was granted on May 31, 2023 and is fully vested and exercisable as of the date hereof. This option was granted on January 5, 2024 and is fully vested and exercisable as of the date hereof. This option was granted on January 3, 2025 and is fully vested and exercisable as of the date hereof. This option was granted on January 6, 2026 and will vest and become exercisable in four equal installments of 7,500 shares on each quarterly anniversary of such grant date, subject to continued service through such dates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does InflaRx (IFRX) director Hege Hellstrom report on this Form 3?
Hege Hellstrom reports existing stock option holdings in InflaRx N.V. The filing lists four stock option grants over ordinary shares with specific exercise prices and expiration dates, establishing her baseline derivative ownership as a company director without showing any new purchases or sales.
Which of Hege Hellstrom’s InflaRx stock options are already vested?
Options granted on May 31, 2023, January 5, 2024 and January 3, 2025 are fully vested and exercisable. These three awards cover 22,500, 30,000 and 30,000 underlying ordinary shares respectively, meaning all those options can be exercised under their stated terms and prices.
How will the January 6, 2026 InflaRx stock option grant vest for Hege Hellstrom?
The January 6, 2026 option for 30,000 shares will vest in four equal installments. Hellstrom will receive 7,500 vested shares on each quarterly anniversary of the grant date, provided she continues serving through each vesting date, gradually increasing her exercisable position.
What are the exercise prices and expirations of Hege Hellstrom’s InflaRx options?
Her options have exercise prices of $4.19, $1.79, $2.41 and $1.17 per share. The awards expire between May 31, 2033 and January 6, 2036, giving a long-dated window during which the vested portions can be exercised under the specified terms.